Mammalian Target of Rapamycin Signaling in the Spinal Cord Is Required for Neuronal Plasticity and Behavioral Hypersensitivity Associated With Neuropathy in the Rat  by Asante, Curtis O. et al.
NThe Journal of Pain, Vol 11, No 12 (December), 2010: pp 1356-1367
Available online at www.sciencedirect.comMammalian Target of Rapamycin Signaling in the Spinal Cord Is
Required for Neuronal Plasticity and Behavioral Hypersensitivity
Associated With Neuropathy in the RatCurtis O. Asante, Victoria C. Wallace, and Anthony H. Dickenson










1356Abstract: The protein kinase mammalian target of rapamycin (mTOR) regulates mRNA translation
and is inhibited by rapamycin. Signaling pathways involving mTOR are implicated in physiological
and pathophysiological processes. We determined the spinal effects of the rapamycin analogue
cell cycle inhibitor (CCI)-779 on neuronal responses and behavioral hypersensitivity in a model of
persistent neuropathic pain. We also assessed the anatomical distribution of spinal mTOR signaling
pathways. Specifically, we ligated rat spinal nerves L5 and L6 to produce a model of neuropathic pain.
After confirming neuropathy with behavioral testing, we obtained in vivo single-unit extracellular
stimulus-evoked recordings from deep dorsal horn spinal neurons. We applied CCI-779 spinally in
electrophysiological and behavioral studies and assessed its effects accordingly. We also used immu-
nohistochemistry to probe for mTOR signaling pathways in dorsal root ganglia (DRG) and the spinal
cord. We found that spinally administered CCI-779 rapidly attenuated calibrated mechanically but not
thermally evoked neuronal responses and mechanically evoked behavioral responses. Immunohisto-
chemistry showed presence of mTOR signaling pathways in nociceptive-specific C-fiber DRG and in
neurons of inner lamina II of the spinal cord. We conclude that alterations in the activity of spinal
mTOR signaling pathways are crucial to the full establishment of spinal neuronal plasticity and
behavioral hypersensitivity associated with nerve injury.
Perspective: This study is consistent with growing evidence implicating mTOR signaling pathways
as important modulators of persistent pain, providing novel insights into the molecular mechanisms
of pain maintenance and potential for novel approaches into treating chronic pain.
ª 2010 by the American Pain Society
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come chronic and severely impair an individual’s
quality of life. Despite an increase in basic and
clinical knowledge, the current available treatment for
neuropathic pain treatment remains inadequate2 and
the search continues not only for improved therapies,
but also for novel targets.
Local mRNA translation is a mechanism by which cells,
and, indeed, neurons can supply proteins to specific loca-
tions. The mammalian target of rapamycin (mTOR),
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16/j.jpain.2010.03.013the immunosuppressant drug rapamycin, regulates sev-
eral intracellular pathways in response to various extra-
cellular signals and thereby regulates mRNA translation.
These pathways involve mTOR-dependent activation of
the 70 kDa ribosomal protein S6 kinase (p70S6K) as well
as the inactivation of the repressor of mRNA translation,
eukaryotic initiation factor 4E (eIF4E) binding protein
(4EBP).4,8 It is perhaps not surprising that mTOR activity
is modified in a wide range of pathological states, such
as cancer, and neurodegenerative disorders, such as
Alzheimer’s disease.11,34
A range of interesting studies has shed light on the
roles of mTOR signaling pathways in neuronal excitabi-
lity. mTOR signaling pathways have been shown to be
important in injury-induced hyperexcitability of Aplysia
axons39 and play time-restricted roles in hippocampal
long-term potentiation (LTP).5 Perhaps more relevant,
local peripheral mTOR signaling pathways have been
shown to play a major role in chronic nerve injury,
since peripherally applied rapamycin attenuates fully
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These studies reveal insights into the possible roles these
mechanisms play in the peripheral and central nervous
systems and, more specifically, chronic pain syndromes.
Our studies focus on central mTOR signaling pathways
in the spinal cord and their role in nerve injury-induced
neuronal and behavioral changes, an area that as well
as peripheral mTOR signaling pathways has gained
much interest in recent times (see Price and Geranton26
for review)
Kim et al14 have shown that spinal protein synthesis is
an important component of the behavioral hypersensi-
tivity induced by injection of formalin into the hind
paw of mice. In addition, Price et al27 have implicated
specific spinal mRNA translation pathways in formalin-
induced behavioral hypersensitivity. Their studies used
mice lacking fragile X mental retardation gene (fmr1),
another protein influencing mRNA translation. fmr1
knockout mice were shown to display reduced
formalin-induced behavioral hypersensitivity compared
to their wild-type littermates. Furthermore, spinal ad-
ministration of rapamycin was ineffective in attenuating
formalin-induced behavioral hypersensitivity in fmr1
mutant mice compared to their wild-type littermates,
showing that mTOR signaling pathways modulate persis-
tent painlike states as well as interact with other mRNA
translation pathways. Interestingly, Codeluppi et al6
have identified a role for nonneuronal spinal mTOR sig-
naling pathways in spinal cord injury in the context of
spinal cord injury. Most recently, Geranton et al7 have
shown that spinal nerve injury-induced behavioral hy-
persensitivity can also be attenuated by spinal adminis-
tration of rapamycin.
We have recently shown that inhibiting mTOR signal-
ing pathways prior to the formalin response attenuates
acute behavioral hypersensitivity and neuronal hyperex-
citability.1 In this present study, we inhibited spinal
mTOR signaling pathways after full establishment of
a persistent painlike state. We used in vivo electrophysi-
ology, behavioral pharmacology, and immunohisto-
chemistry to show that spinally active mTOR signaling
pathways are crucial for the neuronal plasticity and pain-
like behavior resulting from nerve injury. We achieved
this using the rapamycin ester analogue CCI-779 that
displays improved water solubility compared with the
nonester form of rapamycin, making it more suitable
for in vivo studies.15Methods
All studies were carried out in accordance with the UK
Animals (Scientific Procedures) Act 1986 and the Interna-
tional Association for the Study of Pain (IASP) guide-
lines41 and were approved by the United Kingdom
Home Office.Animals
For all studies, male Sprague Dawley rats (250–280 g
for in vivo electrophysiology and 140–160 g for the nerve
injury procedure) were used. All rats were supplied (bredin-house) by the Biological Services Unit (BSU), University
College London, UK.Spinal Nerve Ligation (SNL)
This procedure was completed following a well-
established method.13 Rats were anesthetized in an
induction box with 4% v/v isoflurane in a mixture of ni-
trous oxide (50% v/v) and oxygen (50% v/v). The isoflur-
ane was reduced to 2.5% (areflexia was maintained). A
heating blanket maintained a core temperature of
approx 37C. The left paraspinal muscles were separated
from the spinous processes at the lumbar L4–sacral S2
levels. The L6 transverse process was partially removed
and the L5 and L6 spinal nerves were isolated and tightly
ligated with 6-0 silk threads. This was repeated in sham
rats, except for ligation of the spinal nerves. Rats were
allowed to recover after closing the wound, prior to
sensory testing.Behavioral Studies
Rats were tested on days 2, 7, 9, and 14 after surgery to
assess the progression of painlike behavior with 1, 6, and
8 g von Frey filaments (Touch Test; Stoelting Co., Dublin,
IE) and a cooling stimulus comprising acetone expelled
from a modified syringe attached to a piece of tubing.
The maximal force of each von Frey filament was applied
to the most sensitive part of the ipsilateral and contralat-
eral hind paw a total of 10 times. Acetone was applied to
each hind paw a total of 5 times. Stimuli were applied for
a total of 2 seconds and each set was separated by at least
3 minutes. Withdrawal responses were confirmed by full
lifting of the foot from the stimuli. Difference scores
were used to quantify painlike behavior and were calcu-
lated as follows: Difference score = number of paw with-
drawals from the injured (ipsilateral) side minus number
of paw withdrawals from uninjured (contralateral) side.
To determine the effect of drugs at the spinal level on
painlike behavior, 14 days postsurgery, rats were lightly
anesthetized on 2% isoflurane in a mixture of nitrous ox-
ide (50% v/v) and oxygen (50% v/v), after which 20 mL of
drug solution containing CCI-779 (250 mM or 12.88 mG in
50 mL saline) was injected through the skin and muscle,
into the L5–L6 vertebral interspace, and the rats were al-
lowed to recover for 20 minutes prior to testing. A 20-mL
volume has been shown to produce uniform coverage of
the spinal cord that is restricted to the sacral and cauda
equina levels and extends up to thoracic T13–lumbar
L1.40 The drug regimen was blinded until the analysis
was complete.In Vivo Electrophysiology
This procedure followed a well-established protocol.37
Rats were anesthetized in an induction box with 4% iso-
flurane in a mixture of nitrous oxide (66% v/v) and oxy-
gen (33% v/v). The trachea was exposed and isolated
and a tracheal cannula was inserted and fastened with
3-0 silk threads. At this stage, the isoflurane was reduced
to 2.5% v/v (areflexia was maintained). Rats were then
secured in a stereotaxic frame and a rectal probe
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a core temperature of 37C.
Vertebral segments were specifically removed to ex-
pose L4–L5 of the spinal cord, and muscle and connective
tissue from surrounding areas were kept intact to create
a well at the exposed spinal cord area into which drug so-
lutions were added. The dura mater was removed to aid
drug and electrode penetration. When the set up was
complete, the isoflurane was reduced to 1.8% v/v, a level
sufficient for anesthesia, while maintaining areflexia.
CCI-779 was applied directly onto the exposed spinal
cord in a volume of 50 mL (250 nM or 12.88 nG in
50 mL). Behavioral studies used a higher dose of drug
(250 mM) compared with electrophysiological studies
(250 nM) since 250 mM rapamycin has been shown to
be effective in attenuating capsaicin- and nerve injury-
induced behavioral hypersensitivity when injected
locally into the glabrous skin of the hind paw.12 Further-
more, in a previous study, it was found that while a spinal
dose of .8 mG of the phosphatdylinositol 3-kinase (PI3K)
inhibitor LY294002 was effective in significantly attenu-
ating neuronal excitability in in vivo electrophysiology
experiments, a much higher spinal dose of 100 mG was
required to attenuate persistent behavioral hypersensi-
tivity.22 These differences are likely due to the ease of
applying a drug immediately adjacent to the recording
electrode in a static system so that lower doses appear
more effective for in vivo electrophysiology.
Recordings were obtained with an AC recording sys-
tem (NeuroLog System, Digitimer; Hertfordshire, UK).
An electrode (parylene insulated tungsten microelec-
trode, 125 mM diameter, 2 MU, A-M systems) was manu-
ally lowered into the exposed cord (L4–L5) to a depth of
500–1000 mM. This is an area occupied by wide dynamic
range (WDR) neurons that respond to innocuous and
noxious stimuli. Quantification of neuronal activity was
achieved with a 1401 interface and Spike 4 software
(Cambridge Electronic Design, Cambridge, UK). An oscil-
loscope was used to isolate single neurons and a number
of stimuli were applied to the receptive field. Mechanical
stimuli (von Frey filaments) were applied to the most sen-
sitive part of the receptive field for 10 seconds. This was
also the case for thermal stimuli, where increasing heat
was applied using a jet of water from a 60-mL syringe at-
tached to a needle.
Electrical stimuli via 2 intradermal stimulating elec-
trodes were used to determine Aß- and C-fiber thresh-
olds based on their latencies to respond to stimuli
(Aß-fibers = <20 mS poststimulus; C-fibers = 90–300 mS
poststimulus). A train of 16 stimuli (3 times C-fiber
threshold at .5 Hz, 2 mS pulse width) was delivered to
the receptive field to determine the number of action
potentials attributable to Aß-fibers (0–20 mS); Ad-fibers
(20–90 mS); C-fibers (90–300 mS) and postdischarge
(300–800 mS) due to the wind-up elicited by repeated
stimulation of nociceptive-specific C-fibers. The input
(nonpotentiated C-fiber response) and the wind-up
(potentiated C-fiber response) were calculated as fol-
lows: C-fiber Input = action potentials (90–800 mS)
evoked by the first pulse at 3 times C-fiber threshold mul-
tiplied by the total number of pulses (16). This representsthe theoretical baseline in the absence of wind-up.
C-fiber wind-up = total action potentials (90–800 mS)
after the 16-train stimulus at 3 times C-fiber threshold
minus the input. This represents the excess activity above
the theoretical baseline due to wind-up. Only stable cells
where 3 consecutive stimulus-evoked responses were
within 10% of the previous result for the same test
were selected for further pharmacological study, ie,
a minimum of 3 control tests were carried out prior to
saline or CCI-779 administration. A test comprising
electrical, mechanical, and thermal stimuli was carried
out every 20 minutes. Saline or CCI-779 was administered
20 minutes prior to the first noncontrol test.Immunohisochemistry
Fourteen days postSNL, rats were terminally anesthe-
tized with 1 mL (200 mG) pentobarbital sodium (Euthatal;
Merial Animal Health, Essex, UK) intraperitoneally. The
rats were transcardially perfused with 200 mL saline
with added heparin solution (1000 IU of heparin per l
of saline; LEO Laboratories, Buckinghamshire, UK). This
was followed by 300 mL per rat of 4% w/v paraformalde-
hyde (VWR, Leicestershire, UK) solution in .1 M phosphate
buffer (PB) mixed with .15% picric acid (Sigma-Aldrich
Co., Dorset, UK). Dorsal root ganglia (DRG) from L4, L5,
and L6 were removed from both the ipsilateral and con-
tralateral side of the ligations. The lumbar enlargement
of the spinal cord was also removed. DRG were postfixed
for 2 hours and spinal cord overnight, before being trans-
ferred to a cryoprotectant solution containing 30% w/v
sucrose in .1 M PB and .01% w/v sodium azide (Sigma)
for a minimum of 24 hours. All tissues were embedded
in optimal cutting temperature (OCT) compound and rap-
idly frozen on liquid nitrogen before being stored at
–80C prior to cutting. Transverse sections were cut (20
mM) using a cryostat and mounted on Superfrost Plus
slides (Thermo Fisher Scientific Co., Waltham, MA). These
slides were then stored at –20C in a cryoprotectant solu-
tion comprising 40% v/v phosphate buffered saline (PBS),
30% v/v ethylene glycerol and 30% v/v glycerol.Standard Staining
We probed for the active protein immediately down-
stream of mTOR, phospho p70S6K. All proteins except
phospho p70S6K were probed for using standard stain-
ing techniques. Primary antibodies used included rabbit
anti-calcitonin gene-related peptide (anti-CGRP, 1:4000;
Sigma) and rabbit anti-protein kinase C g (anti-PKCg,
1:500, Santa Cruz, Santa Cruz, CA). For all rabbit anti-
bodies, the secondary antibody was goat anti-rabbit cya-
nine 3 (1:400; Stratech, Newmarket Suffolk, UK).
Cryoprotected Slides containing tissue sections were
washed several times in PBS. A mixture of 10% v/v normal
donkey serum in PBS plus .2% v/v triton X-100 (Sigma)
and .1% w/v sodium azide was applied to slides for 30
minutes. The donkey serum was removed and primary
antibodies in PBS plus .2% v/v triton X-100 and .1% w/v
sodium azide were added to the slides overnight. After
several PBS washes, the secondary fluorescent antibody
was applied and slides were left in the dark for 3 hours.
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ries, Burlingame, CA) solution was placed onto each slide
and a cover slip was positioned over the solution and
tissue.
Tyramide Signal Amplification (phospho
p70S6K)
Slides containing tissue sections were immersed over-
night in antigen unmasking solution (Vector Laborato-
ries) 1:100 in PBS plus .2% v/v triton X-100 and .1% w/v
sodium azide. They were then heated on high power
(800 W) for 1 minute 15 seconds. After 30 minutes cool-
ing and several PBS washes, a solution of .3% v/v H2O2
was applied to the slides for 20 minutes and the slides
were again washed several times in PBS. A 10% v/v nor-
mal donkey serum in PBS plus .2% v/v triton X-100
(Sigma) and .1% w/v sodium azide was applied to slides
for 30 minutes. The serum was removed and primary an-
tibody (rabbit phospho p70S6K Thr389; Cell Signaling
Technology, Inc., Danvers, MA) at a concentration of
1:50 in PBS plus .2% v/v triton X-100 and .1% w/v sodium
azide was added to the slides overnight. After several
PBS washes, the secondary biotinylated antibody (goat
anti-rabbit biotin, Vector Laboratories) was applied at
a concentration of 1:400 for 1.5 hours. After several
PBS washes, slides were incubated with avidin biotin la-
beled complex (ABC Elite, Vector Laboratories, 1:250
PBS Vectastain solution A plus 1:250 PBS Vectastain solu-
tion B) for 30 minutes followed by signal amplification
with biotinylated tyramide solution (1:75 PBS for 10 min-
utes; Perkin Elmer, Waltham, MA). After several PBS
washes, extra-avidin fluorescein isothiocyanate (FITC)
was used to bind to the biotin attached to the tyramide.
Vectashield solution was placed onto each slide and
a cover slip was positioned over the solution and tissue.
Sections were viewed under a Carl Zeiss Axioplan 2
fluorescence microscope (Carl Zeiss, Oberkochen, Ger-
many) and images were taken under 10 or 20  magni-
fication using the same settings for all sections belonging
to the same slide. Postacquisition processing was per-
formed with Adobe Photoshop version 7.0 (Adobe, San
Jose, CA) only after all analysis was complete.
Statistical Analysis
To confirm painlike behavior, comparisons were made
between sham and SNL difference scores using the
Kruskal-Wallis test with Bonferroni’s posttests. The same
tests were used to compare the effects of CCI-779 and sa-
line on behavioral hypersensitivity over 2 hours. Electro-
physiological raw data are presented as mean 6 SEM
response. Student’s unpaired t-tests were used to com-
pare sham and SNL predrug baseline control neuronal re-
sponses with each other, except for graded thermally and
mechanically evoked responses, where 2-way ANOVA
with Bonferroni posttests were used. In addition, maximal
changes in stimulus-evoked responses (positive or nega-
tive within the first hour postdrug administration) were
analyzed. For drug-induced maximal response changes
to electrical, brush, and pinprick stimuli, 1-way ANOVA
with Bonferroni’s multiple comparisons posttests wereused. For maximal changes in graded mechanical and
thermal stimuli-evoked responses, 2-way ANOVA with
Bonferroni’s multiple comparisons posttests were used.
For quantification of spinal cord immunohistochemistry,
minimums of 3 sections were chosen at random from
each rat for each lumbar region (determined with aid of
a spinal cord atlas). Regions of interest templates were
set (1 set of templates for either the ipsilateral or contra-
lateral side) and maintained for all sections throughout
the analysis. Fluorescence levels were determined by cal-
culating the mean grey value using Image J software (Na-
tional Institutes of Health) and corrected for background
levels. All values were then normalized to the side contra-
lateral to the injury. For normalization, all mean grey
values were normalized to the single highest mean grey
value (100%) of the contralateral side of the correspond-
ing segment resulting in overall contralateral fluores-
cence levels being less than 100% since the fluorescence
levels of each segment represent means across multiple
sections. Wilcoxon matched paired tests were then used
to compare the normalized ipsilateral mean grey values
to the normalized contralateral mean grey values.Results
Confirmation of the Painlike State
We have shown that SNL produces robust hypersensi-
tivity to innocuous mechanical and cold stimuli of the in-
nervated hind paw from as early as day 2 postsurgery and
this is maintained for at least 2 weeks (Figs 1A-D). In fact,
this procedure has been found to produce long-lasting
hypersensitivity to noxious heat for at least 5 weeks post-
surgery and mechanical hypersensitivity at least 10 weeks
postsurgery,13 perhaps reflecting the longevity of
chronic human symptoms in this animal model.
Effects of CCI-779 on Neuronal and
Behavioral Responses From Nerve-
Injured Rats
It appears that the changes underlying persistent pain-
like states such as neuropathic pain also change the activ-
ity of mTOR signaling pathways to the extent where they
are more readily inhibited. In agreement with observa-
tions by Suzuki et al,33 evoked neuronal predrug re-
sponses from SNL animals were equivalent to those in
sham animals (Table 1); hence, we pooled SNL and sham
predrug responses into 1 control group. CCI-779 had
a strong inhibitory effect on specific neuronal responses
to electrical and mechanical stimuli from SNL rats com-
pared to predrug control responses and sham rats (Figs
2A-D). When compared to sham rats, C-fiber–mediated
transmission onto WDR neurons in SNL rats was signifi-
cantly inhibited, as were postdischarge and wind-up of
WDR neurons (Figs 2A-B), measures of central hypersensi-
tivity mechanisms. There was also significant inhibition of
punctate mechanically evoked responses to von Frey fila-
ments 8–60 g (Fig 2C). However, this inhibitory action was
highly selective and did not extend to thermally evoked
responses, which were unaltered by the drug (Fig 2D),
suggesting that in SNL rats, mTOR signaling pathways
Figure 1. SNL results in painlike behavior. Paired analysis of difference scores show that after SNL (white, n = 22), there was a signif-
icant increase in paw withdrawals from the injured side versus the uninjured side compared to sham rats (black, n = 24). (A) For a 1 g
stimulus, this increase in behavioral hypersensitivity was most apparent on days 9 and 14. (B-D) For a 6- and 8-g stimulus as well as
acetone, behavioral hypersensitivity was significantly increased as early as day 2 and maintained up to day 14. *P < .01. ***P < .001.
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mechanical stimuli.
Some of the effects of CCI-779 on neuronal measures
were duplicated in awake animals. Behavioral effects
were examined in SNL rats at day 14 (Figs 3A-D). Here,
the rapid effects on withdrawal responses to mechanical
stimuli were much like the effects of the drug seen in the
electrophysiological studies. In most cases, maximal inhi-
bition of difference scores occurred at 20 minutes when
compared to saline administration. For behavioral with-
drawal responses to acetone, inhibition was significant
at 20 and 40 minutes (Figs 3A-D). Also, in most cases,
inhibition returned to baseline levels, except for
withdrawal responses to acetone, where there was a sus-
tained level of inhibition (Fig 3D).Distribution of mTOR Signaling
Pathways
Immunohistochemistry showed that SNL resulted in
a decrease in immunoreactivity in CGRP in superficial
dorsal horn spinal cord regions ipsilateral to the site of
injury (Fig 4A). Much like nociceptive CGRP immunos-
taining, it was found that there was a decrease in immu-
noreactivity for phospho p70S6K in superficial dorsal
horn spinal cord regions corresponding to the ligated
L5 and L6 segments ipsilateral to the site of injury (Fig
4B). Interestingly, immunoreactivity for phosho-p70S6K
was found to be restricted to the inner layer of lamina
II of the dorsal horn and this is an area that is occupied
by small interneurons that are immunoreactive for
PKCg.25 Double labeling spinal cord sections with both
anti-phospho p70S6K and anti-PKCg revealed that neu-
rons positive for phospho p70S6K appear to form partof a population of neurons that are PKCg-positive, al-
though not all PKCg-positive neurons double labeled
for phospho p70S6K (Fig 4C). Immunoreactivity for phos-
pho p70S6K was also examined in DRG as an indicator of
possible activity in primary peripheral afferent terminals
at the level of the spinal cord. Double labeling for phos-
pho p70S6K and CGRP (which is a marker of small, unmy-
elinated neurons) revealed that mTOR signaling
pathways are present in many (but not all) of these neu-
rons at least at the level of the DRG (Fig 4D). Interestingly,
we found no reduction in immunoreactivity in the unin-
jured L4 region, either for CGRP (Fig 5A) or phospho
p70S6K (Fig 5B). The positive results from the DRG sug-
gest that mTOR signaling pathways are present in affer-
ents where actions within central terminals could be
another substrate for spinally applied modulating
agents.
In order to confirm specificity of the secondary goat
anti-rabbit IgG for anti-phospho p70S6K, control experi-
ments were carried out whereby the primary antibody
(anti-phospho p70S6K) was omitted from the protocol.
Here there was an absence of immunoreactive signal
(data not shown). In addition, although the secondary
antibodies used for double labeling were both produced
in rabbit, amplification of the p70S6K signal results in
a complex that is only recognized by a biotinylated sec-
ondary antibody. Although intuitively, one would expect
there to be some cross-reactivity between the secondary
antibodies, it has been shown that when a primary anti-
body is used at a concentration that can only be detected
by a fluorescent amplification method (we saw no detec-
tion without the amplification method), another pri-
mary antibody, raised in the same host species, can be
used and demonstrated with a different flurochrome in
Table 1. Differences Between Baseline WDR
Neurone Responses From Sham and SNL Rats
SHAM (N = 10) SNL (N = 12)
Aß-fiber spikes 87 6 16 111 6 16
Ad-fiber spikes 112 6 19 136 6 15
C-fiber spikes 461 6 55 531 6 57
Post-discharge spikes 293 6 33 245 6 49
Input spikes 480 6 64 464 6 64
Wind up spikes 467 6 46 344 6 82
Brush spikes 572 6 89 445 6 52
Pin spikes 400 6 75 311 6 59
1 g spikes 31 6 17 21 6 10
6 g spikes 195 6 46 125 6 44
8 g spikes 300 6 60 237 6 65
15 g spikes 437 6 83 364 6 84
26 g spikes 570 6 101 479 6 102
60 g spikes 782 6 118 637 6 100
35C spikes 342 6 104 192 6 47
40C spikes 427 6 143 234 6 61
45C spikes 444 6 167 359 6 99
48C spikes 610 6 204 509 6 278
50C spikes 975 6 208 754 6 118
NOTE. The table shows predrug control responses of WDR neurones from sham
and SNL rats. For electrically evoked responses, a train of 16 pulses at 3 times
C-fiber threshold (.5 Hz, 2-mS pulse width) was applied to the corresponding
hind paw. For mechanically evoked responses, von Frey filaments of ascending
force were applied to the corresponding receptive field for 10 seconds. For
thermally evoked responses, a small water jet was applied to the corresponding
receptive field for 10 seconds. All data are expressed as raw mean values6 SEM.
There were no significant differences between WDR neurone responses from
sham or SNL rats prior to CCI-779 administration.
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section since cross-reactivity is not an issue.3,10,38Discussion
In recent years, there has been growing interest in the
roles of mTOR signaling pathways, and particularly, their
roles in neuronal plasticity. Neuronal plasticity is a widely
accepted feature of many persistent pain states observed
clinically. Here, we provide convincing evidence using in
vivo electrophysiology, behavioral pharmacology, and
immunohistochemistry that these pathways contribute
to neuronal plasticity and behavioral hypersensitivity in
a model of chronic neuropathic pain. The list of neuro-
transmitters, receptors, ion channels, and genes that
have been identified as key modulators of persistent
and chronic pain states is extensive. Perhaps most inter-
esting is that many neurotransmitters, receptors, and
ion channels implicated in persistent and chronic pain
states engage mTOR signaling pathways11,34 that may
also regulate the translation of specific pain genes.
Thus, mTOR signaling pathways at the level of mTOR
may represent a convergence point of many
nociceptive signals, which is an intriguing prospect for
future basic and clinical studies.
Our present studies show that nerve injury induces
changes at the spinal level that result in neuronal plastic-
ity and behavioral hypersensitivity and that these
changes depend upon activity of mTOR signaling path-
ways. CCI-779 modulated responses of spinal cord neu-rons in the neuropathic model in a selective manner
since specific measures of central hypersensitivity such
as wind-up and postdischarge were reduced, as was the
C-fiber—evoked activity. With natural stimuli, there
was attenuation of mechanically evoked activity with
no effect at all on thermally evoked responses. These
findings were corroborated by the drug being effective
on mechanical (and cooling) responses in SNL animals.
Of particular interest is that the efficacy of CCI-779 is
specifically increased after direct nerve injury. The effec-
tiveness of the anti-neuropathy drug gabapentin (GBP)
in attenuating neuronal responses of SNL rats32 is similar
to what we observed here although the agents have very
different modes of action. Both drugs were weakly effec-
tive or ineffective on neuronal responses in the absence
of nerve injury.
Our previous studies showed that selective mTOR in-
hibitors such as rapamycin attenuate the neuronal plas-
ticity and behavioral hypersensitivity associated with
formalin by inhibiting mRNA translation since they exert
the same effects as the global mRNA translation inhibitor
anisomycin.1 Therefore, we are confident that CCI-779
acts specifically by inhibiting mTOR signaling pathways.
Although not investigated further in this study, we are
also confident that the results produced in our electro-
physiological and behavioral data reflect a reduction in
p70S6K activity. Our behavioral dose of 250 mM CCI-779
is equivalent to 12.88 mG per 50 mL dose, and Codeluppi
et al6 and Jimenez-Diaz et al12 show that 1 mg/kg and
12.5 mG per 50 mL dose respectively of rapamycin attenu-
ate the phosphorylation of p70S6K. Perhaps more rele-
vant, is a study by Podsypanina et al24 that shows that
a high CCI-779 dose of 20 mg/kg attenuated phospho
p70S6K activity in endogenous tumors.
The relatively restricted neuronal localization of acti-
vated phospho p70S6K is also of interest because these
neurons double label for PKCg, indicating that a propor-
tion of spinal neurons, which contain active mTOR signal-
ing pathways, also express PKCg. PKCg is important
because it has been shown that mice that lack the PKCg
isoenzyme fail to develop neuropathic painlike syndromes
and the neurochemical changes that occur in the spinal
cord after nerve injury.18 Besides being located in inner
lamina II, PKCg interneurons are also present in lamina
III, with some weak immunoreactivity in lamina I and
the outer layer of lamina II. Most PKCg-positive neurons
are not GABA or m-opioid receptor-immunoreactive,25
substantiating their roles as excitatory interneurons
that have roles in the maintenance of persistent painlike
states. Although we failed to detect immunoreactivity
for phospho p70S6K in deeper lamina of the dorsal
horn of the spinal cord, it is not surprising that we still
observed changes in neuronal output from WDR
neurons since it has been previously shown that ablating
lamina I superficial (and to a lesser extent, lamina III)
neurons will affect neuronal excitability of deeper
WDR neurons.31,32 Importantly, responses from WDR
neurons to a wide range of innocuous and noxious
stimuli and their ability to wind up to electrical
stimulation are unique to this class of neurons and the
information we obtain from them can provide an
Figure 2. mTOR signaling pathways are more readily inhibited by CCI-779 in SNL rats. (A) 250 nM CCI-779 inhibited nociceptive-
specific C-fiber–mediated transmission onto WDR neurons from SNL rats (n = 12) compared to sham rats (n = 10) and pooled predrug
controls (n = 22). CCI-779 also had a significant inhibitory effect on WDR neuronal postdischarge (PD) compared to sham rats. (B) CCI-
779 inhibited wind-up, a potentiated response mediated by nociceptive C-fiber activity and a measure of neuronal hyperexcitability
from SNL rats compared to sham rats. (C) CCI-779 was effective in inhibiting neuronal responses to mechanical stimuli from SNL rats
compared to sham rats (8, 15, 26, and 60 g) and pooled predrug controls (15, 26, and 60 g). (D) The inhibitory effects of CCI-779 were
not extended to thermally evoked responses since there were no differences on thermally evoked responses between pooled predrug
controls and CCI-779-treated sham or SNL rats. *P < .05. **P <.01. ***P < .001.
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cord.
Initially, it was widely accepted that PKCg interneurons
in the spinal cord received their input from unmyelinated,
nonpeptidergic, IB4-positive nociceptors.29 However, in
a recent study, it has been shown that the terminal field
of IB4-positive neurons in fact lies dorsal to that of
PKCg interneurons.19 In contrast, medium diameter and
large diameter myelinated afferents that are generally
associated with innocuous signal transmission, exten-
sively overlap with PKCg interneurons. Furthermore,
PKCg interneurons are specifically activated by innocuous
input generated by rotarod-induced locomotion. These
studies suggest that A-fiber—mediated transmission
should be affected by CCI-779 and also that PKCg inter-
neurons may not play an important role in our model
of chronic neuropathic pain. However, when assessing
the effects of CCI-779 on A-fiber—mediated transmis-
sion, we saw no significant effects. This may be due
the fact that A-fibers were stimulated at 3 times the
C-fiber threshold during an electrical stimulus train
and therefore that all A-fiber—mediated changes were
masked. Nevertheless, some of the responses to lower
von Frey filaments (<15 g) are likely A-fiber—mediated
and these responses were amenable to inhibition by
CCI-779.
Despite the fact that we see immunoreactivity for
phospho p70S6K in DRG, it is unlikely that CCI-779 exerts
its effects on primary afferent terminals but rather, exerts
its action specifically on spinal neurons since Geranton et
al7 have recently reported that mTOR signaling pathwaysdo not extend beyond the dorsal root entry zone and
double staining spinal cord sections for phospho mTOR
and synaptophysin, synapsin, or vesicular glutamate
transporter 1 (VGLUT1) did not show localization of
mTOR in axon terminals. Regardless of the specific roles
of PKCg interneurons, they must undoubtedly be impor-
tant in sensory processing in the spinal cord since we
show that phospho p70S6K immunoreactivity of PKCg in-
terneurons and the neuronal and behavioral phenotype
are all altered after nerve injury. Our data shows an over-
all inhibitory effect of CCI-779 on C-fiber–mediated
transmission onto WDR neurons and therefore noxious
stimulus-evoked responses.
Our finding that SNL results in a decrease in immuno-
reactivity for phospho p70S6K in the corresponding lum-
bar spinal segment (L5) is of particular interest because
intuitively, based on previous studies, particularly
concerning neuronal activity in the brain, a condition
like neuropathy would be expected to result in an in-
crease in phospho p70S6K immunoreactivity.5,21,35,36
Intriguingly, one-third of lamina II interneurons receive
simultaneous monosynaptic inputs from 2 to 4 different
segmental roots.23 This model of organization, where
substantia gelatinosia spinal neurons at L4 receive major
monosynaptic input from L4-L6 roots, suggests that the
reduction in L5 phospho p70S6K and CGRP immunoreac-
tivity after SNL should also be observed in L4 (even
though at this level, spinal nerves are not ligated) and
that neurons within L4 will have reduced responses.
However, we find that phospho p70S6K, CGRP immuno-
reactivity are actually maintained in what should be
Figure 3. mTOR signaling pathways contribute to behavioral hypersensitivity displayed by SNL rats. (A) Paired analysis showed that
spinal administration of 250 mM CCI-779 (white) resulted in marked (but not significant) attenuation of behavioral hypersensitivity
compared to saline (black) from baseline (B) levels to a 1 g von Frey filament. Complete (but not significant) inhibition by CCI-779
was observed at 20 and 40 minutes. (B) CCI-779 significantly attenuated behavioral hypersensitivity to 6 g at 40 minutes, with a return
to baseline levels thereafter. (C) CCI-779 significantly attenuated behavioral hypersensitivity to 8 g at 20 minutes, with a return to
baseline levels thereafter. (D) CCI-779 significantly attenuated behavioral hypersensitivity to acetone at 40, 60, and 100 minutes
with some recovery to baseline levels at 120 minutes. *P < .05. **P < .01. ***P < .001.
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difference in neuronal responses between sham and
SNL animals, where in both cases, evoked neuronal
activity is recorded from L4 and L5 segments. These
results can be explained by the following hypotheses
and conclusions.
1. Immunohistochemistry. Ligation of the L5 and L6
spinal nerves result in loss of input to the dorsal
horn of L4 as well as L5 and L6, corresponding
with a reduction in the level of immunohistoche-
mical markers for p70S6K and CGRP in L5. This
should also correspond with a reduction in the level
of immunohistochemical markers for p70S6K and
CGRP in L4. Since this is not the case, we propose
that there is an upregulation of p70S6K phosphory-
lation and CGRP in L4 of the spinal cord that masks
the deficit of these markers.
2. Electrophysiology. Ligation of the L5 and L6 spinal
nerves results in loss of input to the dorsal horn of
L4 as well as L5 and L6 which should correspond
with a reduction in the excitability of WDR neurons
recorded from L4 and L5. Although we did not dis-
tinguish between L5 and L4 neuronal responses in
individual animals, the fact that we see no differ-
ence between responses from sham and neuro-
pathic rats suggests that there may be increase an
excitability of L4 WDR neurons and afferents in neu-ropathic rats which increases the excitability of the
neighboring L5 segment so that WDR neurons in L4
and L5 are also more excitable. This increase in neu-
ronal excitability in neuropathic rats thus masks the
deficit of L5 input. In agreement with these state-
ments, previous studies have shown that spinal
neurons with connections to the periphery expand
their receptive fields after the same nerve ligation,
so that a given spatial stimulus will activate more
spinal neurons compared to sham animals, a likely
substrate for the enhanced nociception present in
this model.30
There may well be local changes in mTOR activity that
were not detected with our methods, such as changes re-
stricted to specific synapses. However, in accordance
with our interpretation of our data is ample evidence
that abnormal neuronal activity from uninjured seg-
ments of the spinal cord contribute to the neuronal
and behavioral phenotypes associated with persistent
painlike states. Specifically, the marker for damaged
neurons-activating transcription factor 3 (ATF3) is en-
hanced in L4 spinal neurons even though L5 spinal
nerves are ligated.28 In injured L5 DRG, SNL has been
found to induce the activation of multiple mitogen-
activated protein kinases (MAPKs) in different popula-
tions of DRG neurons whereas in the uninjured L4
DRG, the L5 SNL induces p38 activation in tyrosine kinase
Figure 4. SNL affects CGRP immunoreactivity and mTOR signaling pathways in L5 spinal neurons. (A) Observation of the stained
tissue sections revealed that immunoreactivity of CGRP in the dorsal horn ipsilateral (Ipsi) to the injury (left) appeared to be lower
when compared to the dorsal horn contralateral (contra) to the injury (middle). This was confirmed by a paired analysis of the
fluorescence of the ipsilateral versus the contralateral side to the injury (right), thus confirming an expected feature of SNL. Scale
bars = 100 mM. (B) Likewise, there appeared to be a reduction in phospho p70S6K in the dorsal horn ipsilateral to the injury (left) com-
pared to the side contralateral to the injury (middle), and this was confirmed by paired analysis of the fluorescence of the ipsilateral
versus the contralateral side to injury (right). Scale bars = 100 mM. (C) Surprisingly, phospho p70S6K was mainly activated in inner lam-
ina II of the dorsal horn of the spinal cord, an area known to be occupied by PKCg-expressing interneurons. Double labeling spinal
cord sections for phospho p70S6K (top) and PKCg (middle) revealed that the 2 signals were at least partially colocalized, suggesting
mTOR signaling pathway activity in a subpopulation of PKCg interneurons (bottom). Scale bars = 50 mM. (D) Double labeling DRG sec-
tions for phospho p70S6K (left) and CGRP (middle) revealed that the 2 signals were at least partially colocalized, suggesting that some
nociceptive-specific fibers utilize mTOR signaling pathways, at least at the level of the DRG (right). Scale bars = 100 mM. *P < .05.
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thermore, L5 SNL has been shown to cause extensive
changes in the electrophysiological profile of large-
and medium-sized, but not small-sized somata of intact
L4 as well as axotomized L5 DRG neurons after L5 spinal
nerve ligation.17 In addition, transient receptor poten-
tial V1 (TRPV1) of the A-fiber somata has been shown
to increase in the uninjured L4 DRG compared to con-
trols,9 and L4 dorsal rhizotomy performed 7 days after
the L5 SNL has been shown to result in an immediate re-
versal of low mechanical withdrawal thresholds back to
baseline values.16Interestingly, CGRP nociceptors were immunoreactive
for phospho p70S6K in DRG. This finding differs from
Geranton et al7 and Jimenez-Diaz et al,12 who found
that within the glabrous skin of the hind paw, the major-
ity of phospho mTOR and mTOR staining was found to
coexist with N52 immunoreactivity in A-fibers. This ap-
parent contradiction appears to be due to a mismatch
between immunoreactivity in DRG and immunoreacti-
vity at peripheral afferent terminals. In support of this
is the finding by Geranton et al7 that phospho mTOR sig-
naling pathways do not extend beyond the dorsal root
entry zone. It is important to note that Jimenez-Diaz
Figure 5. SNL does not affect CGRP and p70S6K immunoreactivity in L4 spinal neurons. (A)Observation of the stained tissue sections
revealed that immunoreactivity of CGRP in the dorsal horn ipsilateral (Ipsi) to the injury (left) appeared unchanged when compared to
the dorsal horn contralateral (contra) to the injury (middle). This was confirmed by a paired analysis of the fluorescence of the ipsi-
lateral versus the contralateral side to the injury (right). (B) Likewise, there appeared to be no change in phospho p70S6K in the dorsal
horn ipsilateral to the injury (left) compared to the side contralateral to the injury (middle), and this was confirmed by paired analysis
of the fluorescence of the ipsilateral versus the contralateral side to injury (right). Scale bars = 100 mM.
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some C-fibers, suggesting that mTOR signaling pathways
are also important in C-fiber–mediated transmission.
Furthermore, the mTOR binding protein raptor was
found to be expressed in a small proportion of N52-
negative fibers and more recently, in a small population
of peripherin (nociceptor marker)-positive neurons. In
these most recent studies by Geranton et al,7 it is re-
ported that signaling pathways involving phospho
mTOR are localized in lamina I and lamina III. However,
we find phospho mTOR labeling in inner lamina II where
activity is localized with PKCg interneurons. It is likely
that our model of neuropathic pain, whereby we ligate
spinal nerves L5 and L6 and euthanize and perfuse on
day 14 postsurgery, results in neuron-specific changes
in mTOR signaling in the entire affected region of the
spinal cord that would not be seen in uninjured animals
like those used by Geranton et al for their immunohisto-
chemistry.7
Our immunohistochemistry data indicates that active
mTOR signaling at the spinal level contributes to the
neuronal plasticity and behavioral hypersensitivity asso-
ciated with persistent painlike states. We hypothesize
that CCI-779 acts on PKCg-positive spinal interneurons,
causing a reduction in nociceptive signals transmitted
by C-fibers. The fact that there is some degree of restric-
tion in terms of the expression of this pathway probably
confers selective modulation of mechanical responses
and hypersensitivity without altering thermal sensory
processing.
In our previous study,1 we showed that rapamycin pro-
duces inhibitory effects on C-fiber activity, mechanically
and thermally evoked responses in naive animals. We
also showed that spinally administered rapamycin atten-
uates formalin-induced hyperexcitability, a finding
which was first shown by Price et al.27 In this study, we
did not observe inhibitory effects by CCI-779 in sham an-imals. Given that CCI-779 is an analogue of rapamycin,
we would expect to see similar effects of CCI-779 on neu-
ronal responses in sham animals. However, it is likely that
although CCI-779 shows improved water solubility, sub-
tle changes in pharmacokinetics, which are dependent
upon the solution into which the compounds are diluted,
may mean that the inhibitory effects are altered at least
in nonpathological states, such that 250 nM rapamycin is
more efficacious than 250 nM CCI-779, at least in our
hands. Importantly, CCI-779 exerts strong inhibitory ef-
fects on SNL-induced behavioral hypersensitivity com-
pared to saline.
Particularly evident in the behavioral studies was that
attenuation of behavioral hypersensitivity was only tem-
porarily inhibited after administration of CCI-779. This
rapid yet temporary maximal effect of CCI-779 indicates
that at least in this pain model, mTOR signaling path-
ways may be continuously active and that their continu-
ous activation rapidly regulates neuronal activity and
behavior. Such rapid signaling, which has a direct effect
on neuronal function, is not a novel concept. In acute
brain slices it has been shown that that the induction
of protein synthesis-dependent hippocampal LTP in-
creases the local expression of elongation factor 1A
(eEF1A) in dendrites that are severed from their cell
bodies before stimulation. This effect is blocked by
rapamycin, indicating that the increase in eEF1A expres-
sion is mediated by mTOR pathway. Remarkably, eEF1A
levels increase within 5 minutes after stimulation in
a translation-dependent manner, and this effect remains
stable for 3 hours.36Conclusions
By focusing on subcellular targets that are implicated
in pain, the hope is that we will be able to produce
selective drug treatments that are more effective and
1366 The Journal of Pain Spinal mTOR Signaling and Pain Processingexert fewer side effects than what is currently available.
These studies, along with our previous studies,1 confirm
that mTOR signaling pathways are important in noci-
ception and persistent painlike states. The widespread
distribution of these pathways as well as their numer-
ous cellular effects that include mediating the immune
response means that the therapeutic potential of CCI-
779 remains in question. However, these studies reveal
that rapid, continuous mTOR signaling at the spinal
level is an integral element of nociception and themaintenance of persistent painlike states involving
central sensitization.
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